NHI analyst estimates
National Health Investors (NHI) analyst ratings, the average price target and its range, and every firm's latest call.
NHI analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Oct 19, 2026 | Wells Fargo | National Health Investors price target lowered to $68 from $78 at Wells Fargo | $68.00 |
| Sep 9, 2026 | National Bank | National Health Investors initiated with an Outperform at Huntington | $79.00 |
| Sep 2, 2026 | Truist Financial | National Health Investors price target lowered to $80 from $81 at Truist | $80.00 |
| Sep 1, 2026 | Wells Fargo | National Health Investors price target lowered to $78 from $79 at Wells Fargo | $78.00 |
| Jun 25, 2026 | Deutsche Bank | National Health Investors price target lowered to $80 from $85 at Deutsche Bank | $80.00 |
| Jun 15, 2026 | BMO Capital | National Health Investors price target lowered to $80 from $90 at BMO Capital | $80.00 |
| Jun 12, 2026 | Truist Financial | National Health Investors price target lowered to $81 from $89 at Truist | $81.00 |
| Mar 27, 2026 | Wells Fargo | National Health Investors price target raised to $86 from $85 at Wells Fargo | $86.00 |
| Jan 20, 2026 | National Bank | National Health Investors downgraded to Hold from Buy at Deutsche Bank | $85.00 |
| Jan 5, 2026 | Cantor Fitzgerald | National Health Investors price target lowered to $85 from $87 at Cantor Fitzgerald | $85.00 |
| Dec 15, 2025 | Truist Financial | National Health Investors (NHI) PT Raised to $83 at Truist Securities | $83.00 |
| Dec 4, 2025 | KeyBanc | National Health Investors price target raised to $88 from $80 at KeyBanc | $88.00 |
| Nov 25, 2025 | Wells Fargo | National Health Investors price target raised to $85 from $80 at Wells Fargo | $85.00 |
| Oct 1, 2025 | National Bank | National Health Investors initiated with an Overweight at Cantor Fitzgerald | $90.00 |
| Jul 2, 2025 | Truist Financial | National Health Investors upgraded to Buy from Hold at Truist | $77.00 |
- 6 firms rate NHI: 4 buy, 2 hold, 0 sell.
- The average price target is $77.40 from 5 analysts, from $68.00 to $80.00.
Updated 2026-11-03 20:07 UTC